Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Koch, Tina K ^a   Reuter, Michael ^a   Barthel, Diana ^a   Böhm, Sascha ^a   van den Elsen, Jean ^b   Kraiczy, Peter ^c   Zipfel, Peter F ^a,d   Skerka, Christine ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b UNIVERSITY OF BATH   (United Kingdom)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; EXTRACELLULAR FIBRINOGEN BINDING PROTEIN; PLASMIN; PLASMINOGEN; SURFACE IMMUNOGLOBULIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; INNATE IMMUNITY; NONHUMAN; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; STAPHYLOCOCCUS AUREUS; SURFACE PLASMON RESONANCE;

BACTERIAL PROTEINS; BLOTTING, WESTERN; CARRIER PROTEINS; CLONING, MOLECULAR; COMPLEMENT C3; COMPLEMENT C3B; COMPLEMENT INACTIVATOR PROTEINS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIN; HUMANS; IMMUNITY, INNATE; PLASMINOGEN; PROTEOLYSIS; STAPHYLOCOCCUS AUREUS; SURFACE PLASMON RESONANCE;

EID: 84867415024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047638     Document Type: Article

References (44)

1. Lowy FD, (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
2. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
3. Walport MJ, (2001) Complement. First of two parts. N Engl J Med 344: 1058-1066.
4. Zipfel PF, Skerka C, (2009) Complement regulators and inhibitory proteins. Nature Reviews Immunology 9: 729-740.
5. Walport MJ, (2001) Complement. Second of two parts. N Engl J Med 344: 1140-1144.
6. Rooijakkers SHM, Ruyken M, Roos A, Daha MR, Presanis JS, et al. (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nature Immunology 6: 920-927.
7. Lambris JD, Ricklin D, Geisbrecht BV, (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6: 132-142.
8. Laarman A, Milder F, van Strijp J, Rooijakkers S, (2010) Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications. Journal of Molecular Medicine 88: 115-120.
9. Hammel M, Sfyroera G, Pyrpassopoulos S, Ricklin D, Ramyar KX, et al. (2007) Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. Journal of Biological Chemistry 282: 30051-30061.
10. Clark EA, Crennell S, Upadhyay A, Zozulya AV, Mackay JD, et al. (2011) A structural basis for Staphylococcal complement subversion: X-ray structure of the complement-binding domain of Staphylococcus aureus protein Sbi in complex with ligand C3d. Molecular Immunology 48: 452-462.
11. Burman JD, Leung E, Atkins KL, O'Seaghdha MN, Lango L, et al. (2008) Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J Biol Chem 283: 17579-17593.
12. Haspel N, Ricklin D, Geisbrecht BV, Kavraki LE, Lambris JD, (2008) Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d. Protein Sci 17: 1894-1906.
13. Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KPM, et al. (2007) Staphylococcal complement evasion by various convertase-blocking molecules. Journal of Experimental Medicine 204: 2461-2471.
14. Hammel M, Sfyroera G, Ricklin D, Magotti P, Lambris JD, et al. (2007) A structural basis for complement inhibition by Staphylococcus aureus. Nature Immunology 8: 430-437.
15. Haupt K, Reuter M, van den Elsen J, Burman J, Hälbich S, et al. (2008) The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog 4: e1000250.
16. Upadhyay A, Burman JD, Clark EA, Leung E, Isenman DE, et al. (2008) Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi. J Biol Chem 283: 22113-22120.
17. Mölkänen T, Tyynelä J, Helin J, Kalkkinen N, Kuusela P, (2002) Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase. FEBS Lett 517: 72-78.
18. Lähteenmäki K, Kuusela P, Korhonen TK, (2001) Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 25: 531-552.
19. Bergmann S, Hammerschmidt S, (2007) Fibrinolysis and host response in bacterial infections. Thromb Haemost 98: 512-520.
20. Lähteenmäki K, Kuusela P, Korhonen TK, (2000) Plasminogen activation in degradation and penetration of extracellular matrices and basement membranes by invasive bacteria. Methods 21: 125-132.
21. Taylor FB, Ward PA, (1967) Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures. J Exp Med 126: 149-158.
22. Ward PA, (1967) A plasmin-split fragment of C'3 as a new chemotactic factor. J Exp Med 126: 189-206.
23. Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, et al. (2008) Interaction between the coagulation and complement system. Adv Exp Med Biol 632: 71-79.
24. Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, et al. (2010) Molecular Intercommunication between the Complement and Coagulation Systems. Journal of Immunology 185: 5628-5636.
25. Seya T, Nagasawa S, Matsukura M, Hasegawa H, Atkinson JP, (1985) Generation of C3d, g and C3d by urokinase-treated plasma in association with fibrinolysis. Complement 2: 165-174.
26. Rooijakkers SHM, van Wamel WJB, Ruyken M, van Kessel KPM, van Strijp JAG, (2005) Anti-opsonic properties of staphylokinase. Microbes and Infection 7: 476-484.
27. Barthel D, Singh B, Riesbeck K, Zipfel PF, (2012) Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J Immunol 188: 379-385.
28. Barthel D, Schindler S, Zipfel PF (2012) Plasminogen is a complement inhibitor. J Biol Chem.
29. Siegel C, Hallström T, Skerka C, Eberhardt H, Uzonyi B, et al. (2010) Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. PLoS One 5: e13519.
30. Hallstrom T, Haupt K, Kraiczy P, Hortschansky P, Wallich R, et al. (2010) Complement Regulator-Acquiring Surface Protein 1 of Borrelia burgdorferi Binds to Human Bone Morphogenic Protein 2, Several Extracellular Matrix Proteins, and Plasminogen. Journal of Infectious Diseases 202: 490-498.
31. Brissette C, Haupt K, Barthel D, Cooley A, Bowman A, et al. (2009) Borrelia burgdorferi Infection-Associated Surface Proteins ErpP, ErpA, and ErpC Bind Human Plasminogen. Infection and Immunity 77: 300-306.
32. Nagasawa S, Stroud RM, (1977) Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b'). Immunochemistry 14: 749-756.
33. Zipfel P, Reuter M, (2009) Complement Activation Products C3a and C4a as Endogenous Antimicrobial Peptides. International Journal of Peptide Research and Therapeutics 15: 87-95.
34. Nordahl EA, Rydengård V, Nyberg P, Nitsche DP, Mörgelin M, et al. (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 101: 16879-16884.
35. Foster TJ, (2005) Immune evasion by staphylococci. Nat Rev Microbiol 3: 948-958.
36. Rooijakkers SHM, Wu J, Ruyken M, van Domselaar R, Planken KL, et al. (2009) Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nature Immunology 10: 721-727.
37. Ricklin D, Tzekou A, Garcia BL, Hammel M, McWhorter WJ, et al. (2009) A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family. J Immunol 183: 2565-2574.
38. Lee L, Hook M, Haviland D, Wetsel R, Yonter E, et al. (2004) Inhibition of complement activation by a secreted Staphylococcus aureus protein. Journal of Infectious Diseases 190: 571-579.
39. Hammel M, Ramyar KX, Spencer CT, Geisbrecht BV, (2006) Crystallization and X-ray diffraction analysis of the complement component-3 (C3) inhibitory domain of Efb from Staphylococcus aureus. Acta Crystallographica Section F-Structural Biology and Crystallization Communications 62: 285-288.
40. Luo S, Poltermann S, Kunert A, Rupp S, Zipfel P, (2009) Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein. Molecular Immunology 47: 541-550.
41. Poltermann S, Kunert A, von der Heide M, Eck R, Hartmann A, et al. (2007) Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans. Journal of Biological Chemistry 282: 37537-37544.
42. Jin T, Bokarewa M, McIntyre L, Tarkowski A, Corey GR, et al. (2003) Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 52: 919-923.
43. Zavizion B, White JH, Bramley AJ, (1997) Staphylococcus aureus stimulates urokinase-type plasminogen activator expression by bovine mammary cells. J Infect Dis 176: 1637-1640.
44. Beaufort N, Wojciechowski P, Sommerhoff CP, Szmyd G, Dubin G, et al. (2008) The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochemical Journal 410: 157-165.